What are the possible causes of unintentional weight loss in a patient with a normal CT scan, otherwise unremarkable laboratory studies, and a serum sodium of 125 mmol/L?

Unintentional Weight Loss with Hyponatremia (Na 125)

The most critical diagnosis to pursue immediately is small cell lung cancer (SCLC) with syndrome of inappropriate antidiuretic hormone (SIADH), as this combination of unintentional weight loss and moderate hyponatremia (125 mmol/L) is a classic paraneoplastic presentation that requires urgent identification and treatment. 1

Primary Diagnostic Consideration: Malignancy with SIADH

The combination you describe—unintentional weight loss with serum sodium of 125 mmol/L and otherwise normal labs—strongly suggests paraneoplastic SIADH from lung cancer, particularly SCLC. Here's why this must be your first consideration:

• 10-45% of SCLC cases produce excess ADH, though only 1-5% become symptomatic 1
• At sodium 125 mmol/L, patients typically experience weakness, confusion, headache, and nausea—symptoms that may be subtle or attributed to other causes 1
• Hyponatremia in SCLC patients is associated with shortened survival, making early detection critical 1
• The "normal" CT may have missed early-stage disease or small lesions, particularly if it wasn't specifically a chest CT with appropriate protocol

Confirm SIADH Diagnosis

Before assuming malignancy, verify true SIADH with these specific criteria 1:

• Serum osmolality < 275 mosm/kg (hypoosmolar)
• Urine osmolality > 300-500 mosm/kg (inappropriately concentrated)
• Urine sodium > 20-40 mEq/L (inappropriately high)
• Serum uric acid < 4 mg/dL
• Euvolemic status on exam (no edema, no orthostasis, no dehydration)
• Exclude hypothyroidism and adrenal insufficiency

Immediate Workup Algorithm

Step 1: Targeted Imaging for Occult Malignancy

Even with a "normal CT," you need:

• Dedicated chest CT with contrast if not already done—SCLC can be small or mediastinal 1
• Age-appropriate cancer screening if not current 2
• Consider PET-CT if initial imaging unrevealing but clinical suspicion remains high

Step 2: Laboratory Panel for Unintentional Weight Loss

The following tests are recommended for all patients with unexplained weight loss 2:

• Complete blood count
• Comprehensive metabolic panel (already have sodium)
• Liver function tests
• Thyroid function tests (TSH, free T4)
• C-reactive protein and ESR (inflammatory markers)
• Lactate dehydrogenase
• Ferritin
• Protein electrophoresis
• Urinalysis
• Fecal occult blood testing

Step 3: Additional SIADH-Specific Testing

• Serum and urine osmolality
• Urine sodium concentration
• Serum uric acid
• Cortisol (morning) to exclude adrenal insufficiency 1

Other Differential Diagnoses to Consider

While malignancy accounts for up to one-third of unintentional weight loss cases 2, other causes include:

Non-Malignant Organic Causes (More Common in Older Adults)

• Gastrointestinal disorders: Consider upper endoscopy/colonoscopy if age-appropriate screening not current 3
• Medication effects: Review all medications for those causing nausea, taste changes, or hyponatremia (SSRIs, carbamazepine, diuretics) 2
• Chronic infections: TB, HIV, endocarditis
• Endocrine disorders: Hyperthyroidism, adrenal insufficiency (though this should cause hyperkalemia too)

Psychiatric Causes

• Depression is a leading cause, particularly in institutionalized older adults 3
• Eating disorders

Social Factors

• Isolation, financial constraints, inability to shop or prepare food 2

Critical Pitfall to Avoid

A completely normal baseline evaluation (including CT) does NOT rule out malignancy. In one prospective study, 0% of patients with malignancy causing weight loss had an entirely normal baseline evaluation 4. However, when baseline evaluation is completely normal, the probability of major organic disease—especially malignancy—drops significantly 4, 5.

The key issue here: your patient has hyponatremia (Na 125), so the baseline evaluation is NOT normal. This abnormality demands explanation and likely represents the pathophysiologic link to the weight loss.

Management Approach

Immediate Hyponatremia Management

With sodium of 125 mmol/L:

• If symptomatic (confusion, severe weakness, nausea): Consider 100-150 mL bolus of 3% hypertonic saline 6, 7
• If asymptomatic: Start with fluid restriction (500 mL/day initially) and adequate solute intake 6
• Monitor sodium frequently to avoid overcorrection (risk of osmotic demyelination syndrome) 8, 6
• Target correction rate: 4-6 mEq/L in first 24 hours, not exceeding 8 mEq/L 6

If SIADH from SCLC is Confirmed

• Treat the underlying malignancy—this is the primary treatment for paraneoplastic SIADH 1
• Fluid restriction as first-line for SIADH management 1
• Consider demeclocycline, lithium, or vaptans (tolvaptan) if fluid restriction fails 1
• Note: Nearly half of SIADH patients don't respond to fluid restriction alone 6

If Initial Workup is Unrevealing

• Close follow-up at 3-6 month intervals is warranted 2, 4
• Up to 25% of unintentional weight loss cases remain unexplained despite comprehensive workup 3
• These patients generally have favorable prognosis 5
• Avoid undirected invasive testing; use watchful waiting 4, 5

Bottom Line

Do not be falsely reassured by "fairly normal" labs when sodium is 125 mmol/L. This is moderate hyponatremia and represents a significant abnormality that, combined with unintentional weight loss, strongly suggests paraneoplastic syndrome from occult malignancy until proven otherwise. Pursue dedicated chest imaging and confirm SIADH criteria immediately.